Abstract:Recent research increasingly validates the early dissemination of tumor cells in peripheral blood during the nascent stages of cancer, often preceding clinical identification of the primary tumor. This emerging evidence emphasizes the potential of Circulating Tumor Cells (CTCs) as early indicators for cancer. Despite their significance, CTCs are exceptionally rare compared to normal blood cells, which presents a considerable challenge in detection, particularly during early stages of cancer. Traditional detection methods, such as those based on nucleated cell enrichment, antibody labeling and fluorescence imaging, encounter notable limitations when applied in the context of early detection. These limitations arise from the inherent heterogeneity of CTCs, and the multistep process involved in labeling and manual enumeration, compromising cell viability and resulting in cell loss. This loss becomes particularly problematic in the context of early cancer detection scenarios where the tumor burden is extremely low, and any cell loss can significantly impact assay sensitivity. To overcome these challenges, we propose an innovative CTC detection approach employing a deep learning framework combined with holographic imaging. This technique utilizes coherent light to generate holograms from cell samples, capturing detailed 3D morphological and optical properties of individual cells. We developed a custom convolutional neural network designed to facilitate high-throughput cell sorting in real-time. Trained on healthy blood samples and diverse cancer cell lines, the dataset consists of more than 50 million cellular holograms enhanced by proprietary Gaussian annotation and image augmentation strategies. Moreover, by combining the morphological signatures from holography with antigen signatures (e.g. HER2/ER/PR) in real-time, our model demonstrates the ability to detect less than 1 false positive per 1 million nucleated cells, highlighting its potential as a robust tool for targeted early-stage breast cancer detection. Our technology represents highly sensitive alternative to traditional screening methods, with the promise of enhancing patient outcomes. Citation Format: Nicholas Heller, Kevin Mallery, Nathaniel Bristow, Yash Travadi, Eng Hock Lee, Jiarong Hong. Detection of early-disseminated cancer cells with deep learning-enabled holographic imaging [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 2304.

Stain-free Holographic Detection of Circulating Tumor Cells Using A Deep Feature Fusion Neural Network

Circulating Tumor Cell Identification Based on Deep Learning

An Innovative Algorithm Combining Attention Mechanism and Feature Fusion for Circulating Tumor Cells Detection

Interpretatively Automated Identification of Circulating Tumor Cells from Human Peripheral Blood with High Performance

Abstract 2304: Detection of early-disseminated cancer cells with deep learning-enabled holographic imaging

A Model for the Detection of Circulating Tumor Cells Based on Micro-OCT Imaging

Intelligent Tumor Cell Detection Method Based on Circulating Tumor Cell (CTC) Technology

Greatly isolated heterogeneous circulating tumor cells using hybrid engineered cell membrane-camouflaged magnetic nanoparticles

A novel combined fluorescent probe staining method for circulating tumor cell identification

Homogeneous two-dimensional visual and fluorescence analysis of circulating tumor cells in clinical samples via steric hindrance regulated enzymes recognition cleavage and elongation

Capture and Identification of Heterogeneous Circulating Tumor Cells Using Transparent Nanomaterials and Quantum Dots-Based Multiplexed Imaging.

Rapid and efficient isolation and detection of circulating tumor cells based on ZnS:Mn 2+ quantum dots and magnetic nanocomposites.

Deep Learning-Assisted Assessing of Single Circulating Tumor Cell Viability via Cellular Morphology

High-Efficiency Isolation and Rapid Identification of Heterogeneous Circulating Tumor Cells (ctcs) Using Dual-Antibody-Modified Fluorescent-Magnetic Nanoparticles

Nondestructive capture, release, and detection of circulating tumor cells with cystamine-mediated folic acid decorated magnetic nanospheres.

FF-CNN: an Efficient Deep Neural Network for Mitosis Detection in Breast Cancer Histological Images.

Nanosphere-based One-Step Strategy for Efficient and Nondestructive Detection of Circulating Tumor Cells.

Simultaneous isolation and detection of circulating tumor cells with a microfluidic silicon-nanowire-array integrated with magnetic upconversion nanoprobes

A Lightweight and Robust Framework for Circulating Genetically Abnormal Cells (CACs) Identification Using 4-Color Fluorescence In Situ Hybridization (FISH) Image and Deep Refined Learning

Ultrasensitive Detection of Circulating Tumor Cells in Clinical Blood Samples by a Three-Dimensional Network Nanovehicle-Based Aptasensor Platform

Direct Detection of Circulating Tumor Cells in Whole Blood Using Time‐Resolved Luminescent Lanthanide Nanoprobes